pCBA.opI-SceI
(Plasmid
#260786)
-
PurposeCodon-optimized meganuclease I-SceI driven by CBA promoter (pHL402b)
-
Depositing Lab
-
Depositing OrganizationUniversity of Massachusetts, Worcester
Located in United States of America -
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 260786 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backboneAmpicillin
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameCodon-optimized meganuclease I-SceI
Resource Information
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Codon-optimized I-SceI shows 2-fold higher expression in HEK293 cells than Addgene plasmid #26477.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCBA.opI-SceI was a gift from Dan Wang (Addgene plasmid # 260786 ; http://n2t.net/addgene:260786 ; RRID:Addgene_260786) -
For your References section:
Viral gene replication enhances AAV vector quality and reduces manufacturing costs. Liu H, Du A, Liu N, Kapadia M, Chen X, Liang J, Lee JS, Xie J, Gao G, Wang D. Mol Ther. 2026 Aug 11:S1525-0016(26)00689-1. doi: 10.1016/j.ymthe.2026.08.008. 10.1016/j.ymthe.2026.08.008 PubMed 42581546